awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39338052-0E56EB86-5B49-4AD9-BF59-5CB68C17879D
Q39338052-0E56EB86-5B49-4AD9-BF59-5CB68C17879D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39338052-0E56EB86-5B49-4AD9-BF59-5CB68C17879D
The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.
P2860
Q39338052-0E56EB86-5B49-4AD9-BF59-5CB68C17879D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39338052-0E56EB86-5B49-4AD9-BF59-5CB68C17879D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39f0863cca7a08ac0cc0bad2fddd14ed89eec0ab
P2860
A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma.